CALCA and prostate cancer: Neuroendocrine cells frequently differentiate in prostate cancer, the peptide increases prostate cancer cells’ invasive and migratory capacity, CGRP serum level correlates with prostate cancer progression in humans, and CGRP receptor mediates prostate cancer cell metastasis to the bone [274,342,343].